Skip to content

Zerigo Handheld System HD-02Recalls & reported problems

Zerigo Health, Inc. · The Zerigo Home Light Therapy System treats chronic dermatological diseases such as Psoriasis, Vitiligo and Eczema. · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00865522000415), received between Dec 19, 2025 and Feb 23, 2026 — classified as 2 injuries.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Patient Device Interaction Problem2
  • Use of Device Problem1

Patient problems

  • Partial thickness (Second Degree) Burn2
  • Discomfort1
  • Erythema1
  • Pain1
  • Purulent Discharge1
  • Skin Discoloration1
  • Superficial (First Degree) Burn1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 23, 2026Use of Device Problem; Patient Device Interaction Problem

    THE MEMBER REACHED TO ZERIGO SUPPORT TEAM "MY CHIN WAS TREATED WITH 10 SQUARES (TEN PUSH DOWNS AND RELEASES). ABOUT 10 MINUTES AFTER THE TREATMENT MY CHIN WAS VERY WARM AND HAD A STINGING SENSATION. THE BLISTERING AND OOZING STARTED TO OCCUR ON FRIDAY EVENING (THE DAY OF TREATMENT). THE AREA IS STILL RED AND OOZING TODAY. THE SKIN ON MY CHIN IS TENDER AND SOMETIMES ITCHY."

    Patient problems: Discomfort; Erythema; Partial thickness (Second Degree) Burn; Purulent Discharge

    MAUDE report 24420654 ↗
  • InjuryDec 19, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    MEMBER STATED THAT THEY EXPERIENCED FIRST- AND SECOND-DEGREE BURNS. MEMBER STATED: "AFTER MY FIRST TREATMENT IT WAS THE NEXT DAY AND I STATED NOTICING BLISTERING AND HAVING LOTS OF PAIN. I FINALLY WENT INTO A WALK IN CLINIC YESTERDAY BECAUSE I HAD ALL THESE OPEN AREAS ON MY CHEST AND ABDOMEN AND THEY WERE DRAINING AN AWFUL SMELLY DISCHARGE FROM THEM. THE DR SAID I HAVE SECOND DEGREE BURNS SO I'M TAKING AN ANTIBIOTIC AND I SEE THE DERMATOLOGIST TOMORROW MORNING."

    Patient problems: Pain; Partial thickness (Second Degree) Burn; Skin Discoloration; Superficial (First Degree) Burn

    MAUDE report 23858180 ↗

Other Light, Ultraviolet, Dermatological devices

All Light, Ultraviolet, Dermatological devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.